PAVmed Inc
NASDAQ:PAVM

Watchlist Manager
PAVmed Inc Logo
PAVmed Inc
NASDAQ:PAVM
Watchlist
Price: 0.5971 USD 1.03% Market Closed
Market Cap: 10.5m USD

Relative Value

The Relative Value of one PAVM stock under the Base Case scenario is 54.0891 USD. Compared to the current market price of 0.5971 USD, PAVmed Inc is Undervalued by 99%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PAVM Relative Value
Base Case
54.0891 USD
Undervaluation 99%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
46
Median 3Y
299.8
Median 5Y
6.8
Industry
2.2
Forward
67
vs History
15
vs Industry
48
Median 3Y
-6.2
Median 5Y
-11.3
Industry
21.9
Forward
-1
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-13.7
Industry
14.1
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-19.5
Industry
19.8
vs History
44
vs Industry
Median 3Y
-0.4
Median 5Y
-0.2
Industry
2.1
vs History
68
vs Industry
12
Median 3Y
310
Median 5Y
12
Industry
2.4
Forward
90.8
vs History
vs Industry
Median 3Y
-95.8
Median 5Y
-194.6
Industry
4.9
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-11.2
Industry
11.5
Forward
-0.7
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-11
Industry
15.7
Forward
-0.6
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-13.3
Industry
14.1
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-12.9
Industry
17.6
vs History
77
vs Industry
49
Median 3Y
49.6
Median 5Y
5
Industry
1.8

Multiples Across Competitors

PAVM Competitors Multiples
PAVmed Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
PAVmed Inc
NASDAQ:PAVM
10m USD 5 0.1 -0.4 -0.4
US
Abbott Laboratories
NYSE:ABT
232.8B USD 5.5 17.2 22.4 32.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
195.1B USD 22.4 78.8 63.6 77.3
US
Boston Scientific Corp
NYSE:BSX
154.3B USD 8.8 75.9 35.8 49.8
US
Stryker Corp
NYSE:SYK
151B USD 6.5 52.8 26.1 31.4
IE
Medtronic PLC
NYSE:MDT
113.3B USD 3.4 24.3 13.6 19.4
DE
Siemens Healthineers AG
XETRA:SHL
52.6B EUR 2.3 25.2 14.1 19.6
US
Becton Dickinson and Co
NYSE:BDX
50.5B USD 2.4 33.2 13.2 24.8
US
Edwards Lifesciences Corp
NYSE:EW
45.2B USD 8.2 10.8 24.7 27.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.2B USD 11.2 49.3 35 39.1
US
Resmed Inc
NYSE:RMD
37.7B USD 7.5 28.7 20.5 23.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
PAVmed Inc
NASDAQ:PAVM
Average EV/EBITDA: 26.9
Negative Multiple: -0.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.4
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
63.6
24%
2.6
US
Boston Scientific Corp
NYSE:BSX
35.8
21%
1.7
US
Stryker Corp
NYSE:SYK
26.1
12%
2.2
IE
Medtronic PLC
NYSE:MDT
13.6
7%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
14.1
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.2
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.7
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35
12%
2.9
US
Resmed Inc
NYSE:RMD
20.5
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
PAVmed Inc
NASDAQ:PAVM
Average EV/EBIT: 34.4
Negative Multiple: -0.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
32.1
22%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
77.3
26%
3
US
Boston Scientific Corp
NYSE:BSX
49.8
31%
1.6
US
Stryker Corp
NYSE:SYK
31.4
16%
2
IE
Medtronic PLC
NYSE:MDT
19.4
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.6
19%
1
US
Becton Dickinson and Co
NYSE:BDX
24.8
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.2
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.1
12%
3.3
US
Resmed Inc
NYSE:RMD
23.2
14%
1.7